Navigation Links
Polyanalgesic Consensus Panel's New Treatment Guidelines Via Intraspinal Infusion for Severe Chronic Pain
Date:10/31/2007

Updated Algorithm Includes PRIALT(R) (ziconotide intrathecal infusion) as a

First-Line Intraspinal Infusion Alternative to Opioid Medications

CHARLESTON, W.Va., Oct. 31 /PRNewswire/ -- The 2007 Polyanalgesic Consensus Panel (PCP) -- a group of leading national pain management physicians from the United States and abroad -- has updated their intraspinal pain treatment guidelines and recommendations. The findings were released this month in Neuromodulation, a neurology and pain publication for physicians. The panel of pain experts revised the guidelines used to determine treatment via intraspinal infusion for patients suffering from severe chronic pain. The updated algorithm includes PRIALT (Elan Corp.) as a first-line alternative for intraspinal infusion to the opioids morphine and hydromorphone

"We did an extensive review of the literature that has been performed and the consensus was the data was very supportive that PRIALT should be considered a first line drug -- one of the first lines for intraspinal infusion you would use for a patient with chronic, severe or moderate pain," said Timothy Deer, MD of the Center for Pain Relief in Charleston, W.V. The group of experts was led by Deer and Samuel Hassenbusch, MD, PhD, of the University of Texas M.D. Anderson Cancer Center in Houston. [Please see important safety information for PRIALT].

In addition, the panel looked at safety as one of the real landmarks of which drugs to put in the algorithm, recognizing patient safety should always come first above helping the pain, added Deer. "Our consensus demonstrates the evidence is fairly strong in support of PRIALT safety and efficacy as a first-line intraspinal infusion treatment option for chronic pain."

In making their new recommendations, the panel reviewed data published since its last meeting in 2003, as well as newly approved drugs and the clinical treatment experience of the consensus panel members. PRIALT was approved by the FDA
'/>"/>

SOURCE Elan Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Consensus on "Combination Therapy" for Breast Cancer
2. Climate Talks Reach Consensus in Bangkok
3. Climate Talks Reach Consensus in Bangkok
4. Advances in Treatment of Cataracts
5. Recommendations for Treatment of Blood Pressue
6. Thyroid hormone treatment hastens recovery after cardiac surgery
7. Feeding channel created by malaria parasite - a new target for malaria treatments
8. Now umbilical cord helps in stroke treatment.
9. Now AIDS treatment comes dirt-cheap
10. Breast cancer treatment to be determined by gene test
11. Hemopurifier may revolutionise AIDS treatment

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...PRNewswire-USNewswire/ -- Speaker Nancy Pelosi and...ing the House passage of H.R. 3962, the Affordable...a vote of 220 to 215. Below are the Speaker,s ope...just received a call from the President of the Uni...reat victory for the American people. I thank the ...
(Date:11/8/2009)...3D Global Solutions is pleased to announce that it...sal effort for ReSound who recently received an aw...tract. The award includes not only the Veterans Ad...nd other federal agencies. , ...obal Solutions is pleased to announce that it has ...
(Date:11/8/2009)...A jury of 8 people in the Western District of Penn...n pain and suffering for a medical malpractice cas...icia Nocera of Thomas E. Crenney and Associates, L...ta Monestersky and against the Uniontown Hospital....al hysterectomy at age 18. , ...
(Date:11/8/2009)...twork of Hispanic health advocates committed to ac..., WASHINGTON, Nov. 7 "...hey have heard the voice of America,s families by .... Now the Senate must deliver, without delay, on t... Dr. Jane L. Delgado, President and CEO of the Nat...
(Date:11/8/2009)...sage of H.R. 3961 to Secure the Stability of Medic... -- Statement Attributable to: J. James Rohack, M.... (Logo: http://www.newscom.com/cgi-bin/prnh/2008...of the House health reform bill, which will help i...ns and calls for swift passage of H.R. 3961 to sec...
Breaking Medicine News(10 mins):Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 3Health News:Pennsylvania Jury Awards $2.3 Million to Fayette County Woman in Medical Malpractice Case 2Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2
...gh School Raises More than $17,000 and Beats S... Cystic Fibrosis Foundation announced today that C...it Vestavia Hills High School in Birmingham, Ala.,...,000 for the CureFinders (R) program for the 20...
...Ovarian Cancer Coalition Says Gynecologic Health E... Factors , , DALLAS, May 5 At Mother,s Day, a ne...n (NOCC), www.ovarian.org , reveals some startl...g or skipping their annual gynecological exams alt...
...Experienced Law Firm Provides Informational Resour... Houston, TX (PRWEB) May 5, 2009 -- In res... loss products, Williams Kherkher has taken action...each efforts, it has launched an online resource c...
...May 5 Increased public and private expenditure on...ical insurance coverage and continued foreign dono...or growth within the Kenyan healthcare industry. T...enforcement. , , (Logo: http://www.newscom.com/...
...Sweden Tops List, Niger Ranks Last, United States ... Westport, Conn. (Vocus) May 5, 2009 -...es to be a mother, while sub-Saharan African count...organization,s State of the World,s Mothers 2009 ...
...prescription supply for $10 via free mail delivery... , , BENTONVILLE, Ark., May 5 Today in Michigan...r a 90-day supply of 300 generic prescriptions, ea...age of this new affordable pharmacy program from W...
Other Medicine News:Health News:CW's 7th Heaven Actress Mackenzie Rosman to Visit Birmingham Area High School to Honor Cystic Fibrosis Foundation Fundraising 2Health News:Women's Gynecological Exams: Another Victim of the Troubled Economy? 2Health News:Williams Kherkher Warns of Liver Damage, Failure from Hydroxycut 2Health News:Higher Outlays and Improved Regulatory Enforcement Create Opportunities in the Kenyan Healthcare Industry, Reveals Frost & Sullivan 2Health News:Higher Outlays and Improved Regulatory Enforcement Create Opportunities in the Kenyan Healthcare Industry, Reveals Frost & Sullivan 3Health News:A Mother's Report Card: The Best - and Worst - Countries for Mothers 2Health News:A Mother's Report Card: The Best - and Worst - Countries for Mothers 3Health News:New Walmart Program Broadens Access to Affordable Prescriptions in Michigan 2Health News:New Walmart Program Broadens Access to Affordable Prescriptions in Michigan 3
(Date:11/6/2009)... SCOLR Pharma, Inc. (Amex...three and nine months ended September 30, 2009. ...and CEO, said, "We continue to advance discussions...ation. Several potential partners have committed s...al resources as they evaluate the potential commer...
(Date:11/6/2009)...wswire-FirstCall/ -- Recession in domestic and int...Allied Healthcare Products in the first quarter of... Sales declines pushed Allied into a loss for the ...745,000, or negative 9 cents per share, compared t... or 3 cents per share. ,, Sales fell about 21 ...
(Date:11/6/2009)... 6 DUSA Pharmaceuticals,...pany that is developing and marketing Levulan(...focused on patients with common skin conditions, a...tive Officer, will present a corporate overview at...Tuesday, November 10, 2009 at 10:00 a.m. ET at the...
Breaking Medicine Technology:SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 2SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 3SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 4SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 5SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 6SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 7SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 8SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 9Recession Continues to Depress Sales at Allied Healthcare Products 2Recession Continues to Depress Sales at Allied Healthcare Products 3Recession Continues to Depress Sales at Allied Healthcare Products 4Recession Continues to Depress Sales at Allied Healthcare Products 5Recession Continues to Depress Sales at Allied Healthcare Products 6VIA Pharmaceuticals Receives Favorable Hearing Decision From NASDAQ 5420 1VIA Pharmaceuticals Receives Favorable Hearing Decision From NASDAQ 5420 2VIA Pharmaceuticals Receives Favorable Hearing Decision From NASDAQ 5420 3VIA Pharmaceuticals Receives Favorable Hearing Decision From NASDAQ 5420 4New old drug fights colon cancer 59359 1New old drug fights colon cancer 59359 2NIH awards more than 2454 Million to Kaiser Permanente to conduct health research 59355 1NIH awards more than 2454 Million to Kaiser Permanente to conduct health research 59355 2
...udies examining the effects of stem cell source an...s will be explored at a press conference taking pl...e 50th Annual Meeting of the American Society of H...s from a study examining a specialized technique f...lood for transplantation will also be shared durin...
...y assessing the quality of care for patients with ...ngs will be presented at a press conference on Sat...nnual Meeting of the American Society of Hematolog...ning methods that help determine stroke risk in ch...y examining the effects of long-term hydroxyurea u...
Other Medicine Technology:Research Explores the Effects of Stem Cell Source and Patient Age on Stem Cell Transplantation Outcomes 2Research Explores the Effects of Stem Cell Source and Patient Age on Stem Cell Transplantation Outcomes 3Research Explores the Effects of Stem Cell Source and Patient Age on Stem Cell Transplantation Outcomes 4Research Explores the Effects of Stem Cell Source and Patient Age on Stem Cell Transplantation Outcomes 5Research Explores the Effects of Stem Cell Source and Patient Age on Stem Cell Transplantation Outcomes 6Research Explores the Effects of Stem Cell Source and Patient Age on Stem Cell Transplantation Outcomes 7Research Explores the Effects of Stem Cell Source and Patient Age on Stem Cell Transplantation Outcomes 8Studies Examine Quality of Care for Hospitalized Sickle Cell Disease Patients and Effective Methods for Detecting Risk of Stroke in Children With This Disorder 2Studies Examine Quality of Care for Hospitalized Sickle Cell Disease Patients and Effective Methods for Detecting Risk of Stroke in Children With This Disorder 3Studies Examine Quality of Care for Hospitalized Sickle Cell Disease Patients and Effective Methods for Detecting Risk of Stroke in Children With This Disorder 4Studies Examine Quality of Care for Hospitalized Sickle Cell Disease Patients and Effective Methods for Detecting Risk of Stroke in Children With This Disorder 5Studies Examine Quality of Care for Hospitalized Sickle Cell Disease Patients and Effective Methods for Detecting Risk of Stroke in Children With This Disorder 6Studies Examine Quality of Care for Hospitalized Sickle Cell Disease Patients and Effective Methods for Detecting Risk of Stroke in Children With This Disorder 7Studies Examine Quality of Care for Hospitalized Sickle Cell Disease Patients and Effective Methods for Detecting Risk of Stroke in Children With This Disorder 8Studies Examine Quality of Care for Hospitalized Sickle Cell Disease Patients and Effective Methods for Detecting Risk of Stroke in Children With This Disorder 9
Lempert Bone Rongeurs Curved
Horsley Bulldog Bone Rongeur
Stille-Luer Bone Rongeurs
Ruskin Double Action Bone Rongeur Heavy Model
Medicine Products: